INCOME STATEMENT
Torrent Pharmaceuticals Ltd.
BSE
Jun 16, 09:51
3221.95
-28.90 ( -0.89%)
Volume
240
Prev. Close
3250.85
Open Price
3233.05
Bid Price(Qty.)
3216.35 (7)
Offer Pr.(Qty.)
3219.75 (4)
NSE
Jun 16, 09:39
3227.30
-25.20 ( -0.77%)
Volume
69658
Prev. Close
3252.50
Open Price
3250.00
Bid Price(Qty.)
3226.20 (165)
Offer Pr.(Qty.)
3227.30 (9)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE685A01028
|
Market Cap. ( ₹ in Cr. )
|
109226.50
|
P/BV
|
14.56
|
Book Value ( ₹ )
|
221.73
|
BSE Code
|
500420
|
52 Week High/Low ( ₹ )
|
3591/2756
|
FV/ML
|
5/1
|
P/E(X)
|
57.16
|
NSE Code
|
TORNTPHARMEQ
|
Book Closure
|
20/06/2025
|
EPS ( ₹ )
|
56.46
|
Div Yield (%)
|
0.99
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 9485.00 | 8369.59 | 7546.76 | 6665.96 | 6333.04 |
Other Operating Revenues | 197.00 | 163.31 | 148.44 | 76.36 | 117.53 |
Total Operating Revenues | 9682.00 | 8532.90 | 7695.20 | 6742.32 | 6450.57 |
| | | | | |
Other Income | 32.00 | 91.36 | 81.88 | 204.17 | 118.34 |
Total Revenue | 9714.00 | 8624.26 | 7777.08 | 6946.49 | 6568.91 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1518.00 | 1651.91 | 1477.42 | 1528.60 | 1420.82 |
Purchase Of Stock-In Trade | 732.00 | 548.48 | 533.56 | 397.24 | 398.99 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -9.00 | -68.61 | 128.44 | -18.34 | -150.14 |
Employee Benefit Expenses | 1636.00 | 1450.67 | 1251.22 | 1097.93 | 1097.12 |
Finance Costs | 213.00 | 303.04 | 297.68 | 236.29 | 334.12 |
Depreciation And Amortisation Expenses | 760.00 | 761.05 | 672.34 | 602.43 | 609.84 |
Other Expenses | 2230.00 | 2061.15 | 1839.40 | 1636.13 | 1492.05 |
Total Expenses | 7080.00 | 6707.69 | 6200.06 | 5480.28 | 5202.80 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2634.00 | 1916.57 | 1577.02 | 1466.21 | 1366.11 |
| | | | | |
Exceptional Items | -24.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | 2610.00 | 1916.57 | 1577.02 | 1466.21 | 1366.11 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 722.00 | 321.67 | 274.20 | 253.27 | 247.77 |
Deferred Tax | 0.00 | 237.82 | 251.43 | 221.49 | -19.51 |
Total Tax Expenses | 722.00 | 559.49 | 525.63 | 474.76 | 228.26 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1888.00 | 1357.08 | 1051.39 | 991.45 | 1137.85 |
| | | | | |
Profit/Loss From Continuing Operations | 1888.00 | 1357.08 | 1051.39 | 991.45 | 1137.85 |
| | | | | |
Profit/Loss For The Period | 1888.00 | 1357.08 | 1051.39 | 991.45 | 1137.85 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 55.79 | 40.10 | 31.07 | 58.59 | 67.24 |
Diluted EPS (Rs.) | 55.79 | 40.10 | 31.07 | 58.59 | 67.24 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 1015.34 | 863.03 | 676.89 | 338.45 |
Equity Dividend Rate (%) | 640.00 | 560.00 | 440.00 | 960.00 | 700.00 |